Costa Carlos
SEC CIK 1939167 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| FHTX | Foghorn Therapeutics Inc. | CHRO | 35.8K | — | $591.2K | 6 | 2024-09-16 | 2024-09-20 |
Most active insiders at FHTX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | GOTTSCHALK ADRIAN | CEO, Dir | — | — |
Costa Carlos made no open-market trades at FHTX in the last 12 months.
Transactions 6
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2024-09-24 | 2024-09-20+ | FHTX | Foghorn Therapeutics Inc. | Costa Carlos | CHRO | M - OptEx | $3.72 | +36.6K | 35.8K | New | +$136.2K |
| DMT | 2024-09-24 | 2024-09-20+ | FHTX | Foghorn Therapeutics Inc. | Costa Carlos | CHRO | S - Sale+OE | $10.04 | -36.6K | 0 | -100% | -$367.7K |
| DT | 2024-09-20 | 2024-09-18 | FHTX | Foghorn Therapeutics Inc. | Costa Carlos | CHRO | M - OptEx | $3.72 | +11.6K | 11.6K | New | +$43.1K |
| DT | 2024-09-20 | 2024-09-18 | FHTX | Foghorn Therapeutics Inc. | Costa Carlos | CHRO | S - Sale+OE | $10.05 | -11.6K | 0 | -100% | -$116.3K |
| DMT | 2024-09-18 | 2024-09-16+ | FHTX | Foghorn Therapeutics Inc. | Costa Carlos | CHRO | M - OptEx | $3.72 | +10.7K | 10.3K | New | +$39.7K |
| DMT | 2024-09-18 | 2024-09-16+ | FHTX | Foghorn Therapeutics Inc. | Costa Carlos | CHRO | S - Sale+OE | $10.04 | -10.7K | 0 | -100% | -$107.1K |
Purchase Sale Sale after option exercise All abbreviations